ZYFLO CR is a Oral Tablet, Multilayer, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Chiesi Usa, Inc.. The primary component is Zileuton.
Product ID | 10122-902_66955d15-d2e7-4513-abb1-dfb8c8aae090 |
NDC | 10122-902 |
Product Type | Human Prescription Drug |
Proprietary Name | ZYFLO CR |
Generic Name | Zileuton |
Dosage Form | Tablet, Multilayer, Extended Release |
Route of Administration | ORAL |
Marketing Start Date | 2007-05-30 |
Marketing Category | NDA / NDA |
Application Number | NDA022052 |
Labeler Name | Chiesi USA, Inc. |
Substance Name | ZILEUTON |
Active Ingredient Strength | 600 mg/1 |
Pharm Classes | 5-Lipoxygenase Inhibitors [MoA],Decreased Leukotriene Production [PE],5-Lipoxygenase Inhibitor [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2007-05-30 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA022052 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2007-05-30 |
Marketing End Date | 2019-12-31 |
Marketing Category | NDA |
Application Number | NDA022052 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2007-05-30 |
Marketing End Date | 2019-12-31 |
Ingredient | Strength |
---|---|
ZILEUTON | 600 mg/1 |
SPL SET ID: | 9bc08d7b-13da-444f-ac8a-3714a05176cc |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
10122-902 | ZYFLO CR | zileuton |
31722-044 | Zileuton | Zileuton |
49884-723 | Zileuton | zileuton |
64380-189 | Zileuton | zileuton |
64980-206 | Zileuton | Zileuton |
66993-485 | Zileuton | Zileuton |
68180-169 | ZILEUTON | Zileuton |
69339-130 | Zileuton | zileuton |
10122-901 | ZYFLO | zileuton |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
ZYFLO CR 77189433 3427882 Live/Registered |
CHIESI USA, INC. 2007-05-24 |